Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Stephen M Campbell a National Primary Care Research and Development
Centre, University of Manchester, Manchester M13 9PL, b Prescribing
Support Unit, Brunswick Court, Leeds LS2 7RJ
Correspondence to: S M Campbell
stephen.campbell{at}man.ac.uk
Objectives:
To identify prescribing indicators based
on prescribing analysis and cost (PACT) data that have face validity for measuring quality or cost minimisation.
Design:
Modified two round Delphi questionnaire
requiring quantitative and qualitative answers.
Setting:
Health authorities in England.
Participants:
All health authority medical and
pharmaceutical advisers in the first round and lead prescribing
advisers for each health authority in the second round.
Main outcome measures:
Face validity (median rating of
7-9 on a nine point scale without disagreement) and reliability (rating
8 or 9) of indicators for assessing quality and cost minimisation.
Results:
Completed second round questionnaires were received from 79 respondents out of 99. The median rating was 7 for
cost minimisation and 6 for quality, and in all except four cases
individual respondents rated indicators significantly higher for cost
than for quality. Of the 41 indicators tested, only seven were rated
valid and reliable for cost minimisation and five for quality.
Conclusion:
The 12 indicators rated as valid by
leading prescribing advisers had a narrow focus and would allow only a limited examination of prescribing at a general practice, primary care
group, or health authority level.
Read all Rapid Responses